Rand-Hendriksen K - Search Results

1

Estimating an EQ-5D-5L Value Set for China.

Luo N, Liu G, Li M, Guan H, Jin X, Rand-Hendriksen K. Luo N, et al. Among authors: rand hendriksen k. Value Health. 2017 Apr;20(4):662-669. doi: 10.1016/j.jval.2016.11.016. Epub 2017 Feb 9. Value Health. 2017. PMID: 28408009 Free article.

2

EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes.

Oppe M, Rand-Hendriksen K, Shah K, Ramos-Goñi JM, Luo N. Oppe M, et al. Among authors: rand hendriksen k. Pharmacoeconomics. 2016 Oct;34(10):993-1004. doi: 10.1007/s40273-016-0404-1. Pharmacoeconomics. 2016. PMID: 27084198 Free PMC article.

3

Less Is More: Cross-Validation Testing of Simplified Nonlinear Regression Model Specifications for EQ-5D-5L Health State Values.

Rand-Hendriksen K, Ramos-Goñi JM, Augestad LA, Luo N. Rand-Hendriksen K, et al. Value Health. 2017 Jul-Aug;20(7):945-952. doi: 10.1016/j.jval.2017.03.013. Epub 2017 May 9. Value Health. 2017. PMID: 28712624 Free article. Clinical Trial.

4

EQ-5D-5L Valuation for the Malaysian Population.

Shafie AA, Vasan Thakumar A, Lim CJ, Luo N, Rand-Hendriksen K, Md Yusof FA. Shafie AA, et al. Among authors: rand hendriksen k. Pharmacoeconomics. 2019 May;37(5):715-725. doi: 10.1007/s40273-018-0758-7. Pharmacoeconomics. 2019. PMID: 30535779

5

Learning effects in time trade-off based valuation of EQ-5D health states.

Augestad LA, Rand-Hendriksen K, Kristiansen IS, Stavem K. Augestad LA, et al. Value Health. 2012 Mar-Apr;15(2):340-5. doi: 10.1016/j.jval.2011.10.010. Epub 2012 Jan 27. Value Health. 2012. PMID: 22433766 Free article.

6

Comparison of health state values derived from patients and individuals from the general population.

Gandhi M, Tan RS, Ng R, Choo SP, Chia WK, Toh CK, Lam C, Lee PT, Latt NKZ, Rand-Hendriksen K, Cheung YB, Luo N. Gandhi M, et al. Among authors: rand hendriksen k. Qual Life Res. 2017 Dec;26(12):3353-3363. doi: 10.1007/s11136-017-1683-5. Epub 2017 Aug 14. Qual Life Res. 2017. PMID: 28808840

7

Time trade-off and ranking exercises are sensitive to different dimensions of EQ-5D health states.

Rand-Hendriksen K, Augestad LA. Rand-Hendriksen K, et al. Value Health. 2012 Jul-Aug;15(5):777-82. doi: 10.1016/j.jval.2012.04.002. Epub 2012 Jun 7. Value Health. 2012. PMID: 22867789 Free article.

8

Does the Introduction of the Ranking Task in Valuation Studies Improve Data Quality and Reduce Inconsistencies? The Case of the EQ-5D-5L.

Ramos-Goñi JM, Rand-Hendriksen K, Pinto-Prades JL. Ramos-Goñi JM, et al. Among authors: rand hendriksen k. Value Health. 2016 Jun;19(4):478-86. doi: 10.1016/j.jval.2016.02.002. Epub 2016 Mar 31. Value Health. 2016. PMID: 27325340 Free article. Clinical Trial.

9

Impact of transformation of negative values and regression models on differences between the UK and US EQ-5D time trade-off value sets.

Augestad LA, Rand-Hendriksen K, Kristiansen IS, Stavem K. Augestad LA, et al. Pharmacoeconomics. 2012 Dec 1;30(12):1203-14. doi: 10.2165/11595420-000000000-00000. Pharmacoeconomics. 2012. PMID: 23116290

10

Comparison of hypothetical and experienced EQ-5D valuations: relative weights of the five dimensions.

Rand-Hendriksen K, Augestad LA, Kristiansen IS, Stavem K. Rand-Hendriksen K, et al. Qual Life Res. 2012 Aug;21(6):1005-12. doi: 10.1007/s11136-011-0016-3. Epub 2011 Sep 20. Qual Life Res. 2012. PMID: 21932138

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters